jRCT2031240688招募中不适用
Observer -masked comparative study of STN1014003 ophthalmic solution and latanoprost ophthalmic solution in patients with open-angle glaucoma/ocular hypertension and open-label long-term study -Phase III-
试验速览
- 阶段
- 不适用
- 状态
- 招募中
- 入组人数
- 230
- 主要终点
- -
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
- 分配方式
- Randomized Controlled Trial
- 干预模型
- Parallel Assignment
- 主要目的
- Treatment Purpose
- 盲法
- Single Blind
入排标准
- 年龄范围
- 18age old over 至 No limit（—）
- 性别
- All
入选标准
- •18 years of age or older.
- •Diagnosis of OAG or OHT in both eyes
- •Best corrected visual acuity (BCVA) in any eye is 0.20 or better in decimal visual acuity
- •Willingness and ability to give signed informed consent and follow study instructions
排除标准
- •Clinically significant ocular disease
- •History of angle closure glaucoma, or narrow angles
- •Previous glaucoma intraocular surgery
- •Clinically significant systemic disease
- •Participation in any investigational study within 30 days prior to screening
- •Women of childbearing potential who are pregnant, nursing, planning a pregnancy, or not using a medically acceptable form of birth control
结局指标
主要结局
-
Mean diurnal IOP at Week 4
次要结局
未报告次要终点
研究者
相似试验
已完成
1 期
A phase I study of STN1013400 ophthalmic solution in healthy adult male volunteerMyopiaJPRN-jRCT2031210208Migita Yukie48
招募中
1 期
A phase I/IIa study of STN1014100 ophthalmic solution in healthy adult male volunteers and dry eye patientsDry eyeJPRN-jRCT2051220152Koji Oka134
已完成
1 期
A phase I study of STN1013600 ophthalmic solution in healthy adult male volunteerPresbyopiaJPRN-jRCT2031210614Migita Yukie24
招募中
不适用
A Phase IIb study of STN1014100 ophthalmic solution in patients with dry eyeDry eyejRCT2031250105Santen pharmaceutical co.,ltd400
已完成
3 期
WP-1303 Phase III long-term studyJapanease patients with POAG, normal-tension glaucoma, exfoliation glaucoma, pigmentary glaucoma or OHJPRN-jRCT2080224167Wakamoto pharmaceutical Co., Ltd360